Advate rAHF-PFM

antihemophilic factor (recombinant) with procoagulant activity · Baxalta (now part of Shire)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Advate rAHF-PFM, covering 2013-03-26 to 2013-03-26. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic Comparison of Advate rAHF-PFM With Recombinate rAHF in Patients With Severe Hemophilia A [Phase 4]

See pricing